January 27th, 2008 Posted by: Dr. Dobson
Washington — The Jan. 14 announcement of findings from the Enhance trial, which compared patients on the cholesterol-lowering drug Vytorin — a combination of ezetimibe and simvastatin — with a statin alone, sent shockwaves through the medical community. After all, many physicians viewed this as a promising approach in reducing heart disease risk because the drugs it combined work differently to reduce LDL cholesterol.
Read the rest of this entry »
Popularity: unranked [?]
Tags:
Promising,
trial,
statin,
add-in,
falls,
studies,
continue
Posted in Men`s Health, Medical Industry, Drugs, Medicine | No Comments »
December 2nd, 2007 Posted by: Dr. Dobson
Hormonal birth control pills may increase markers of cardiovascular disease risk and the chance of developing cervical cancer, according to a handful of studies published and presented at medical meetings within the past month. Experts say, however, that while these studies help paint a more complete picture of the effects of this form of contraception, the positives still outweigh the negatives.
Read the rest of this entry »
Popularity: unranked [?]
Tags:
Studies,
increased,
heart,
risks,
positives,
still,
outweigh,
negatives
Posted in Women`s Health, Men`s Health, Medical Industry, Medicine | No Comments »